This is a working overview of CJC-1295, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-18. Anything still debated is marked as such rather than presented as settled.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (no linker) | ~3.37 kDa | Calculated from peptide sequence |
| Molecular weight (with linker) | ~3.65 kDa | Includes albumin-binding moiety |
| Appearance | White to off-white powder | Typically lyophilized |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Common synonyms | Modified GRF(1-29), DAC:GRF | Usage varies by source |
== N == N-formylmethionine - N-formylmethionine leucyl-phenylalanine - N-methyl-D-aspartate receptor - N-methylaspartate - N-terminus - NADH - NADPH - NaKATPase - native state - nef gene product - neoplasm protein - Nernst equation - nerve - nerve growth factor - nerve growth factor receptor - nerve tissue protein - nerve tissue protein S 100 - nervous system - neurobiology - neurofilament protein - neurokinin A - neurokinin K - neurokinin-1 receptor - neurokinin-2 receptor - neuron - neuronal cell adhesion molecule - neuropeptide - neuropeptide receptor - neuropeptide Y - neuropeptide Y receptor - neuroscience - neurotensin - neurotensin receptor - neurotransmitter - neurotransmitter receptor - neutral theory of molecular evolution - neutron - neutron activation analysis - NF-kappa B - nicotinic receptor - nitrogen - nitroglycerine - Nobel Prize in Chemistry - non-competitive inhibition - nuclear lamina - nuclear localization signal - nuclear magnetic resonance - NMR - nuclear protein - nucleic acid - nucleic acid regulatory sequence - nucleic acid repetitive sequence - nucleic acid sequence homology - nucleon - nucleophile - nucleoside - nucleosome - nucleotide - nutrition
Opioid withdrawal can occur with a sudden decrease in, or cessation of, opioids after prolonged use. Onset of withdrawal depends on the half-life of the opioid that was used last. With heroin this typically occurs five hours after use. With methadone, it may take two days. How long major symptoms last also depends on the opioid used. For heroin withdrawal, symptoms are typically greatest at two to four days and can last up to two weeks. Less significant symptoms may last longer, in which case the withdrawal is known as post-acute-withdrawal syndrome.
Hydrocodone/ibuprofen, sold under the brand name Vicoprofen among others, is a fixed-dose combination analgesic medication used in short-term therapy to relieve severe pain. Hydrocodone/ibuprofen contains hydrocodone bitartrate, an opioid analgesic agent; and ibuprofen, a nonsteroidal anti-inflammatory agent.
== Ion cyclotron resonance heating == Ion cyclotron resonance heating (or ICRH) is a technique in which electromagnetic waves with frequencies corresponding to the ion cyclotron frequency is used to heat up a plasma. The ions in the plasma absorb the electromagnetic radiation and as a result of this, increase in kinetic energy. This technique is commonly used in the heating of tokamak plasmas.
Sources: en.wikipedia.org
The earliest study of the nervous system dates to ancient Egypt. Trepanation, the surgical practice of either drilling or scraping a hole into the skull for the purpose of curing head injuries or mental disorders, or relieving cranial pressure, was first recorded during the Neolithic period. Manuscripts dating to 1700 BC indicate that the Egyptians had some knowledge about symptoms of brain damage. Early views on the function of the brain regarded it to be a "cranial stuffing" of sorts. In Egypt, from the late Middle Kingdom onwards, the brain was regularly removed in preparation for mummification. It was believed at the time that the heart was the seat of intelligence. According to Herodotus, the first step of mummification was to "take a crooked piece of iron, and with it draw out the brain through the nostrils, thus getting rid of a portion, while the skull is cleared of the rest by rinsing with drugs." Greek thinkers, beginning with Alcmaeon of Croton, advanced the cephalocentric hypothesis that the brain is the seat of sensation and thought. The view that the heart was the source of consciousness was not challenged until the time of the Greek physician Hippocrates. He believed that the brain was not only involved with sensation—since most specialized organs (e.g., eyes, ears, tongue) are located in the head near the brain—but was also the seat of intelligence. Plato also speculated that the brain was the seat of the rational part of the soul.
Portal is a 2007 puzzle-platform game developed and published by Valve. It was originally released in a bundle, The Orange Box, for Windows, Xbox 360 and PlayStation 3, and has been ported to other systems, including Mac OS X, Linux, Android (via Nvidia Shield), and Nintendo Switch. Portal is a first person game. It consists primarily of a series of puzzles that must be solved by teleporting the player's character and simple objects using the "Aperture Science Handheld Portal Device", also referred to as the "portal gun", a device that can create portals between locations in the puzzles. The player character, Chell, is challenged and taunted by an artificial intelligence construct named GLaDOS (Genetic Lifeform and Disk Operating System) to complete each puzzle in the Aperture Science Enrichment Center using the portal gun with the promise of receiving cake when all the puzzles are completed. The Source engine's physics system allows kinetic energy to be retained through portals, requiring creative use of portals to maneuver through the test chambers. This gameplay element is based on a similar concept from the game Narbacular Drop; many of the team members from the DigiPen Institute of Technology who worked on Narbacular Drop were hired by Valve for the creation of Portal. Portal was acclaimed as one of the most original games of 2007, despite some criticism for its short duration. It received praise for its originality, unique gameplay, dark story and sense of comedy.
Pressure-driven operations microfiltration ultrafiltration nanofiltration reverse osmosis gas separation Concentration driven operations dialysis pervaporation forward osmosis artificial lung Operations in an electric potential gradient electrodialysis membrane electrolysis e.g. chloralkaline process electrode ionization electro filtration fuel cell Operations in a temperature gradient membrane distillation
Colin Shindler, first professor of Israel Studies in the UK; founding chairman of the European Association of Israeli Studies (EAIS); author of ten books including History Of Modern Israel(Cambridge University Press); main interests lie in evolution of Israeli Right, changes in the approach of the British and European Left towards Israel since 1948 and emigration movement of Soviet Jews between 1917 and 1991; Israel and the European Left: Between Solidarity and Delegitimisation (Continuum/Bloomsbury) was one of first books to examine history of relationship between the British Left and Israel; also wrote Vladimir Jabotinsky, Menahem Begin and Avraham Stern, The Rise of the Israeli Right: From Odesa to Hebron (Cambridge University Press) which was awarded gold medal in The Washington Institute's for Near East Policy's Book Prize competition; writes for the Jewish Chronicle, Jerusalem Post, Haaretz, History Today, Times Literary Supplement; author of over 650 articles and reviews on Israel and Jewish political history. Avi Shlaim, writer, of Iraqi Jewish and Mizrahi Jewish origin; his work focuses on Zionist settlement of the land of Palestine, history of the Nakba and dispossession of Palestinian land. He is one of Israel's New Historians, a group of Israeli scholars who put forward critical interpretations of the history of Zionism and Israel.
The first 24 hours of treatment entails 1ml/kg/% BSA of crystalloids plus 1 ml/kg/% BSA colloids plus 2000ml glucose in water, and in the next 24 hours, crystalloids at 0.5 ml/kg/% BSA, colloids at 0.5 ml/kg/% BSA, and the same amount of glucose in water.
Sources: en.wikipedia.org
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.
Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.
The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.